Abraham Ceesay - Net Worth and Insider Trading
Abraham Ceesay Net Worth
The estimated net worth of Abraham Ceesay is at least $25 Million dollars as of 2026-09-11. Abraham Ceesay is the CEO of Rapport Therapeutics Inc and owns about 561,435 shares of Rapport Therapeutics Inc (RAPP) stock worth over $24 Million. Abraham Ceesay is the Director of Pacira BioSciences Inc and owns about 9,039 shares of Pacira BioSciences Inc (PCRX) stock worth over $227,421. Abraham Ceesay is also the President of Cerevel Therapeutics Holdings Inc and owns about 0 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $0. Details can be seen in Abraham Ceesay's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Abraham Ceesay has not made any transactions after 2026-09-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Abraham Ceesay
Abraham Ceesay Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Abraham Ceesay owns 5 companies in total, including scPharmaceuticals Inc (SCPH) , Cerevel Therapeutics Holdings Inc (CERE) , and Pacira BioSciences Inc (PCRX) among others .
Click here to see the complete history of Abraham Ceesay’s form 4 insider trades.
Insider Ownership Summary of Abraham Ceesay
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SCPH | scPharmaceuticals Inc | 2017-11-16 | Chief Operating Officer |
| CERE | Cerevel Therapeutics Holdings Inc | 2022-09-08 | President |
| PCRX | Pacira BioSciences Inc | 2025-09-04 | director |
| 2026-09-08 | director & Chief Executive Officer | ||
| 2025-05-20 | director |
Abraham Ceesay Latest Holdings Summary
Abraham Ceesay currently owns a total of 3 stocks. Among these stocks, Abraham Ceesay owns 561,435 shares of Rapport Therapeutics Inc (RAPP) as of September 8, 2026, with a value of $24 Million and a weighting of 99.08%. Abraham Ceesay owns 9,039 shares of Pacira BioSciences Inc (PCRX) as of September 4, 2025, with a value of $227,421 and a weighting of 0.92%. Abraham Ceesay also owns 0 shares of Cerevel Therapeutics Holdings Inc (CERE) as of September 8, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of Abraham Ceesay
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics Inc | 2026-09-08 | 561,435 | 43.46 | 24,399,965 |
| PCRX | Pacira BioSciences Inc | 2025-09-04 | 9,039 | 25.16 | 227,421 |
| CERE | Cerevel Therapeutics Holdings Inc | 2022-09-08 | 0 | 44.96 | 0 |
Holding Weightings of Abraham Ceesay
Abraham Ceesay Form 4 Trading Tracker
According to the SEC Form 4 filings, Abraham Ceesay has made a total of 12 transactions in Rapport Therapeutics Inc (RAPP) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Rapport Therapeutics Inc is the sale of 8,210 shares on September 8, 2026, which brought Abraham Ceesay around $374,458.
According to the SEC Form 4 filings, Abraham Ceesay has made a total of 1 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Pacira BioSciences Inc is the sale of 2,354 shares on September 4, 2025, which brought Abraham Ceesay around $64,005.
According to the SEC Form 4 filings, Abraham Ceesay has made a total of 4 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the sale of 19,210 shares on September 8, 2022, which brought Abraham Ceesay around $624,325.
Insider Trading History of Abraham Ceesay
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Abraham Ceesay Trading Performance
Abraham Ceesay Ownership Network
Ownership Network List of Abraham Ceesay
Ownership Network Relation of Abraham Ceesay

Abraham Ceesay Owned Company Details
What does scPharmaceuticals Inc do?
Who are the key executives at scPharmaceuticals Inc?
Abraham Ceesay is the Chief Operating Officer of scPharmaceuticals Inc. Other key executives at scPharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , 10 percent owner 5am Partners Iv, Llc , and director & President and CEO John H Tucker .
scPharmaceuticals Inc (SCPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of scPharmaceuticals Inc (SCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of scPharmaceuticals Inc (SCPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
scPharmaceuticals Inc (SCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
scPharmaceuticals Inc Insider Transactions
Abraham Ceesay Mailing Address
Above is the net worth, insider trading, and ownership report for Abraham Ceesay. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Abraham Ceesay's mailing address is: Burlington Ma 01830.